Norwegian biotech firm Vestland Pharma has secured NOK 12 million in funding from venture capital group Sarsia and seafood giant Coast Seafood to fast-track the launch of its new natural salmon lice treatment.
Source link
About us
At Blue Economy, we are dedicated to bringing you the latest news, insights, and developments in the world of water, kelp, and seaweed farms. Our mission is to inform, educate, and inspire our readers about the immense potential and importance of sustainable aquaculture.
Must Read
UN Global Seaweed Initiative: Annual meeting
Advancing sustainable seaweed value chains for climate, biodiversity...
Seaweed at Scale : A Global Perspective into Implementation
Great seaweed session at the ChangeNOW Summit on...
The Global Seaweed Coalition is hiring a fundraising manager
The Global Seaweed Coalition (GSC) is looking for...
Subscribe
© 2024 Blue Economy. All Rights Reserved.